KFS
OCRX

KMS Financial Services’s Ocera Therapeutics, Inc. OCRX Stock Holding History

KMS Financial Services’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$99K Buy
20,250
+10,250
+103% +$59.2K 0.01% 518
2014
Q2 		$76K Buy
+10,000
New +$79.7K 0.01% 535

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return

KMS Financial Services's OCRX Position: Q3 2014 in Review

KMS Financial Services increased its Ocera Therapeutics, Inc. (OCRX) stake by 103% in Q3 2014, buying an estimated $59.2K and bringing the position to 20,250 shares worth $99K. The position accounts for 0.01% of the portfolio, ranked #518.

KMS Financial Services first reported a position in OCRX in Q2 2014 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold OCRX as of Q3 2014.

  • KMS Financial Services held 20,250 shares of Ocera Therapeutics, Inc. worth $99K as of Q3 2014.
  • KMS Financial Services bought 10,250 Ocera Therapeutics, Inc. shares in Q3 2014, an estimated $59.2K.
  • Ocera Therapeutics, Inc. made up 0.01% of KMS Financial Services's portfolio in Q3 2014, its #518 holding.
  • KMS Financial Services first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2014.

Based on KMS Financial Services's 13F filing for Q3 2014, filed 14 Nov 2014.